Fresenius Medical Care, depositary receipt
US3580291066, FMS

Name: Fresenius Medical Care (FMS) Stock Price Quote
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

Add a stock to WL

Choose all Reset all

Save Close

Fresenius Medical Care, сountry — Germany

No trading data

Data display in a chart | table

Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

More than 2,500 records have been found, please specify your request

No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

Bond Search

Watchlist

Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issuer

Profile

Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. The Company operates in two business segments: North America and International. The North America segment consists of Renal Therapy Group and Fresenius Medical Services. The International segment consists of Europe and Latin America and one Asia-Pacific unit. During the year ended December 31, 2010, the Company's subsidiary, U.S. Vascular Access Holdings, LLC, completed the acquisition of National Vascular Care Inc.; it acquired a total of 168 existing clinics, and acquired Gambro ABs peritoneal dialysis (PD) business. The Company has a total of 1000 subsidiaries worldwide.

Show more Hide

Issuer

Fresenius Medical Care
Full borrower / issuer name

Fresenius Medical Care AG&Co
Industry

Medical Services

IFRS/US GAAP reports

2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017



	IV q eng
2016



	IV q eng
2015



	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Indicators

News

25/08/2023	Fitch Affirms Fresenius Medical Care at 'BBB-'; off RWN; Outlook Negative (Rating action commentary)
25/05/2023	S&P Global Ratings affirms Fresenius Medical Care at "BBB-" (Local Currency LT credit rating); outlook negative
25/05/2023	S&P Global Ratings affirms Fresenius Medical Care at "BBB-" (Foreign Currency LT credit rating); outlook negative
28/02/2023	Moody's Investors Service revised outlook on Fresenius Medical Care to negative and affirmed at "Baa3" (LT- foreign currency) credit rating
28/02/2023	Moody's Investors Service revised outlook on Fresenius Medical Care to negative and affirmed at "Baa3" (LT- local currency) credit rating

Fresenius Medical Care, depositary receipt
US3580291066, FMS

Stock information

Latest quotes